TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T25057 XX ID T25057 XX DT 21.10.2004 (created); cch. DT 08.05.2014 (updated); spk. CO Copyright (C), QIAGEN. XX FA alpha-synuclein XX SY NACP; non A-beta component of AD amyloid; non-A4 component of amyloid precursor; PARK1; PD1; SNCA; synuclein, alpha (non A4 component of amyloid precursor). XX OS human, Homo sapiens OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates XX GE G010154 SNCA; HGNC: SNCA. XX EX brain,,,adult; detectable; immunoprecipitation; protein; [15] [16]. XX IN T04997 p53; rat, Rattus norvegicus. XX BS R39749. BS R39750. XX DR TRANSPATH: MO000044264. DR EMBL: D31839; DR UniProtKB: P37840; XX RN [1]; RE0025014. RX PUBMED: 11431533. RA Shimura H., Schlossmacher M. G., Hattori N., Frosch M. P., Trockenbacher A., Schneider R., Mizuno Y., Kosik K. S., Selkoe D. J. RT Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. RL Science 293:263-269 (2001). RN [2]; RE0025090. RX PUBMED: 12859888. RA Giasson B. I., Lee V. M. RT Are ubiquitination pathways central to Parkinson's disease? RL Cell 114:1-8 (2003). RN [3]; RE0025094. RX PUBMED: 15364911. RA Hodara R., Norris E. H., Giasson B. I., Mishizen-Eberz A. J., Lynch D. R., Lee V. M., Ischiropoulos H. RT Functional Consequences of {alpha}-Synuclein Tyrosine Nitration. RL J. Biol. Chem. 279:47746-47753 (2004). RN [4]; RE0035826. RX PUBMED: 15207266. RA Dalfo E., Barrachina M., Rosa J. L., Ambrosio S., Ferrer I. RT Abnormal alpha-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease. RL Neurobiol. Dis. 16:92-97 (2004). RN [5]; RE0035864. RX PUBMED: 12121974. RA Pan Z. Z., Bruening W., Giasson B. I., Lee V. M., Godwin A. K. RT Gamma-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways. RL J. Biol. Chem. 277:35050-35060 (2002). RN [6]; RE0045855. RX PUBMED: 12928483. RA Iwata A., Maruyama M., Akagi T., Hashikawa T., Kanazawa I., Tsuji S., Nukina N. RT Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies RL Hum. Mol. Genet. 12:2625-35 (2003). RN [7]; RE0049443. RX PUBMED: 16096643. RA Sato S., Chiba T., Sakata E., Kato K., Mizuno Y., Hattori N., Tanaka K. RT 14-3-3eta is a novel regulator of parkin ubiquitin ligase. RL EMBO J. 25:211-221 (2006). RN [8]; RE0049642. RX PUBMED: 12672538. RA Wersinger C., Sidhu A. RT Attenuation of dopamine transporter activity by alpha-synuclein. RL Neurosci. Lett. 340:189-192 (2003). RN [9]; RE0052187. RX PUBMED: 17039976. RA Paciello O., Wojcik S., Engel W. K., McFerrin J., Askanas V. RT Parkin and its association with alpha-synuclein and AbetaPP in inclusion-body myositis and AbetaPP-overexpressing cultured human muscle fibers. RL Acta Myol. 25:13-22 (2006). RN [10]; RE0052960. RX PUBMED: 18329380. RA Tashiro M., Kojima M., Kihara H., Kasai K., Kamiyoshihara T., Ueda K., Shimotakahara S. RT Characterization of fibrillation process of alpha-synuclein at the initial stage. RL Biochem. Biophys. Res. Commun. 369:910-914 (2008). RN [11]; RE0054411. RX PUBMED: 11438481. RA Sharma N., Hewett J., Ozelius L. J., Ramesh V., McLean P. J., Breakefield X. O., Hyman B. T. RT A close association of torsinA and alpha-synuclein in Lewy bodies: a fluorescence resonance energy transfer study. RL Am. J. Pathol. 159:339-344 (2001). RN [12]; RE0055969. RX PUBMED: 11687285. RA Payton J. E., Perrin R. J., Clayton D. F., George J. M. RT Protein-protein interactions of alpha-synuclein in brain homogenates and transfected cells. RL Mol. Brain Res. 95:138-145 (2001). RN [13]; RE0063103. RX PUBMED: 18975920. RA Luk K. C., Mills I. P., Trojanowski J. Q., Lee V. M. RT Interactions between Hsp70 and the hydrophobic core of alpha-synuclein inhibit fibril assembly. RL Biochemistry 47:12614-12625 (2008). RN [14]; RE0069968. RX PUBMED: 11447312. RA Kuusisto E., Salminen A., Alafuzoff I. RT Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies. RL Neuroreport 12:2085-2090 (2001). RN [15]; RE0025046. RX PUBMED: 12695511. RA Ihara M., Tomimoto H., Kitayama H., Morioka Y., Akiguchi I., Shibasaki H., Noda M., Kinoshita M. RT Association of the cytoskeletal GTP-binding protein Sept4/H5 with cytoplasmic inclusions found in Parkinson's disease and other synucleinopathies. RL J. Biol. Chem. 278:24095-24102 (2003). RN [16]; RE0025092. RX PUBMED: 12551928. RA Snyder H., Mensah K., Theisler C., Lee J., Matouschek A., Wolozin B. RT Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function. RL J. Biol. Chem. 278:11753-11759 (2003). XX //